annual EBIT:
$49.62M+$23.95M(+93.25%)Summary
- As of today (June 23, 2025), TGTX annual earnings before interest & taxes is $49.62 million, with the most recent change of +$23.95 million (+93.25%) on December 31, 2024.
- During the last 3 years, TGTX annual EBIT has risen by +$392.08 million (+114.49%).
- TGTX annual EBIT is now at all-time high.
Performance
TGTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$12.22M-$20.29M(-62.40%)Summary
- As of today (June 23, 2025), TGTX quarterly earnings before interest & taxes is $12.22 million, with the most recent change of -$20.29 million (-62.40%) on March 1, 2025.
- Over the past year, TGTX quarterly EBIT has increased by +$20.61 million (+245.71%).
- TGTX quarterly EBIT is now -89.61% below its all-time high of $117.64 million, reached on September 30, 2023.
Performance
TGTX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$70.37M+$20.61M(+41.44%)Summary
- As of today (June 23, 2025), TGTX TTM earnings before interest & taxes is $70.37 million, with the most recent change of +$20.61 million (+41.44%) on March 1, 2025.
- Over the past year, TGTX TTM EBIT has increased by +$16.69 million (+31.10%).
- TGTX TTM EBIT is now -34.96% below its all-time high of $108.19 million, reached on June 30, 2024.
Performance
TGTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TGTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +93.3% | +245.7% | +31.1% |
| 3 y3 years | +114.5% | +118.4% | +122.0% |
| 5 y5 years | +129.6% | +124.5% | +138.4% |
TGTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +114.5% | -89.6% | +116.2% | -35.0% | +122.0% |
| 5 y | 5-year | at high | +114.5% | -89.6% | +113.3% | -35.0% | +120.5% |
| alltime | all time | at high | +114.5% | -89.6% | +113.3% | -35.0% | +120.5% |
TGTX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $12.22M(-62.4%) | $70.37M(+41.4%) |
| Dec 2024 | $49.62M(+93.3%) | $32.51M(+115.3%) | $49.75M(+781.7%) |
| Sep 2024 | - | $15.10M(+43.4%) | $5.64M(-94.8%) |
| Jun 2024 | - | $10.53M(-225.5%) | $108.19M(+101.6%) |
| Mar 2024 | - | -$8.39M(-27.6%) | $53.67M(+109.0%) |
| Dec 2023 | $25.68M(-112.0%) | -$11.60M(-109.9%) | $25.68M(-167.0%) |
| Sep 2023 | - | $117.64M(-367.5%) | -$38.34M(-79.8%) |
| Jun 2023 | - | -$43.98M(+20.9%) | -$190.15M(+3.5%) |
| Mar 2023 | - | -$36.39M(-51.9%) | -$183.66M(-14.0%) |
| Dec 2022 | -$213.62M(-37.6%) | -$75.61M(+121.3%) | -$213.62M(-7.2%) |
| Sep 2022 | - | -$34.17M(-8.9%) | -$230.27M(-18.0%) |
| Jun 2022 | - | -$37.49M(-43.5%) | -$280.70M(-12.3%) |
| Mar 2022 | - | -$66.35M(-28.1%) | -$320.08M(-6.5%) |
| Dec 2021 | -$342.46M(+25.4%) | -$92.26M(+9.1%) | -$342.46M(+1.6%) |
| Sep 2021 | - | -$84.60M(+10.1%) | -$337.13M(-0.3%) |
| Jun 2021 | - | -$76.87M(-13.4%) | -$338.08M(+8.4%) |
| Mar 2021 | - | -$88.73M(+2.1%) | -$311.87M(+14.2%) |
| Dec 2020 | -$273.05M(+62.9%) | -$86.93M(+1.6%) | -$273.05M(+22.0%) |
| Sep 2020 | - | -$85.55M(+68.9%) | -$223.80M(+12.7%) |
| Jun 2020 | - | -$50.66M(+1.5%) | -$198.64M(+8.5%) |
| Mar 2020 | - | -$49.91M(+32.5%) | -$183.12M(+9.3%) |
| Dec 2019 | -$167.58M(-2.9%) | -$37.67M(-37.6%) | -$167.58M(-8.7%) |
| Sep 2019 | - | -$60.39M(+71.9%) | -$183.55M(+17.0%) |
| Jun 2019 | - | -$35.14M(+2.2%) | -$156.89M(-5.3%) |
| Mar 2019 | - | -$34.38M(-35.9%) | -$165.67M(-4.2%) |
| Dec 2018 | -$172.60M(+46.7%) | -$53.64M(+59.0%) | -$172.87M(+15.9%) |
| Sep 2018 | - | -$33.73M(-23.2%) | -$149.18M(+1.5%) |
| Jun 2018 | - | -$43.92M(+5.6%) | -$147.03M(+11.8%) |
| Mar 2018 | - | -$41.58M(+38.8%) | -$131.54M(+11.8%) |
| Dec 2017 | -$117.63M(+49.0%) | -$29.95M(-5.2%) | -$117.63M(+5.3%) |
| Sep 2017 | - | -$31.59M(+11.1%) | -$111.70M(+6.3%) |
| Jun 2017 | - | -$28.43M(+2.7%) | -$105.04M(+13.4%) |
| Mar 2017 | - | -$27.67M(+15.1%) | -$92.64M(+17.3%) |
| Dec 2016 | -$78.97M(+25.0%) | -$24.03M(-3.6%) | -$78.97M(+7.4%) |
| Sep 2016 | - | -$24.93M(+55.6%) | -$73.52M(+18.6%) |
| Jun 2016 | - | -$16.02M(+14.5%) | -$62.00M(-1.3%) |
| Mar 2016 | - | -$13.99M(-24.7%) | -$62.83M(-0.6%) |
| Dec 2015 | -$63.18M(+13.4%) | -$18.57M(+38.5%) | -$63.18M(-1.3%) |
| Sep 2015 | - | -$13.41M(-20.5%) | -$64.04M(-5.6%) |
| Jun 2015 | - | -$16.86M(+17.5%) | -$67.85M(+8.1%) |
| Mar 2015 | - | -$14.34M(-26.2%) | -$62.74M(+12.6%) |
| Dec 2014 | -$55.72M(+185.4%) | -$19.43M(+12.9%) | -$55.72M(+33.6%) |
| Sep 2014 | - | -$17.22M(+46.5%) | -$41.71M(+44.8%) |
| Jun 2014 | - | -$11.75M(+60.5%) | -$28.81M(+23.1%) |
| Mar 2014 | - | -$7.32M(+35.0%) | -$23.40M(+19.9%) |
| Dec 2013 | -$19.53M(-21.7%) | -$5.42M(+25.7%) | -$19.53M(+14.5%) |
| Sep 2013 | - | -$4.32M(-32.0%) | -$17.05M(+12.1%) |
| Jun 2013 | - | -$6.34M(+84.3%) | -$15.21M(+35.7%) |
| Mar 2013 | - | -$3.44M(+17.0%) | -$11.21M(-55.1%) |
| Dec 2012 | -$24.95M(+2728.5%) | -$2.94M(+18.6%) | -$24.95M(+10.6%) |
| Sep 2012 | - | -$2.48M(+5.8%) | -$22.56M(+12.2%) |
| Jun 2012 | - | -$2.35M(-86.3%) | -$20.11M(+11.3%) |
| Mar 2012 | - | -$17.18M(+2995.4%) | -$18.06M(-5.7%) |
| Dec 2011 | -$882.00K(-56.3%) | -$554.90K(+1743.5%) | -$19.15M(-12.2%) |
| Sep 2011 | - | -$30.10K(-89.9%) | -$21.81M(+2.0%) |
| Jun 2011 | - | -$297.00K(-98.4%) | -$21.39M(-1.1%) |
| Mar 2011 | - | -$18.27M(+468.6%) | -$21.61M(+457.6%) |
| Dec 2010 | -$2.02M | -$3.21M(-922.1%) | -$3.88M(+285.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $390.80K(-174.4%) | -$1.00M(-43.9%) |
| Jun 2010 | - | -$525.10K(-0.8%) | -$1.79M(+2.7%) |
| Mar 2010 | - | -$529.40K(+55.1%) | -$1.74M(-1.6%) |
| Dec 2009 | -$1.77M(-59.9%) | -$341.30K(-13.7%) | -$1.77M(+28.6%) |
| Sep 2009 | - | -$395.60K(-17.1%) | -$1.38M(-41.8%) |
| Jun 2009 | - | -$477.30K(-14.4%) | -$2.37M(-29.5%) |
| Mar 2009 | - | -$557.30K(-1165.6%) | -$3.36M(-23.9%) |
| Dec 2008 | -$4.41M(-63.7%) | $52.30K(-103.8%) | -$4.41M(-30.9%) |
| Sep 2008 | - | -$1.38M(-5.7%) | -$6.38M(-17.2%) |
| Jun 2008 | - | -$1.47M(-9.1%) | -$7.71M(-31.0%) |
| Mar 2008 | - | -$1.61M(-15.9%) | -$11.16M(-8.1%) |
| Dec 2007 | -$12.14M(+21.4%) | -$1.92M(-29.1%) | -$12.14M(-9.4%) |
| Sep 2007 | - | -$2.71M(-45.0%) | -$13.41M(+5.9%) |
| Jun 2007 | - | -$4.92M(+89.8%) | -$12.66M(+25.4%) |
| Mar 2007 | - | -$2.59M(-18.4%) | -$10.10M(+1.0%) |
| Dec 2006 | -$10.00M(-48.3%) | -$3.18M(+61.8%) | -$10.00M(-53.2%) |
| Sep 2006 | - | -$1.97M(-16.6%) | -$21.35M(+0.5%) |
| Jun 2006 | - | -$2.36M(-5.6%) | -$21.24M(+4.2%) |
| Mar 2006 | - | -$2.50M(-82.8%) | -$20.40M(+5.4%) |
| Dec 2005 | -$19.36M(+215.1%) | -$14.53M(+680.4%) | -$19.36M(+192.3%) |
| Sep 2005 | - | -$1.86M(+23.3%) | -$6.62M(-5.4%) |
| Jun 2005 | - | -$1.51M(+3.6%) | -$7.00M(+8.1%) |
| Mar 2005 | - | -$1.46M(-18.7%) | -$6.48M(+5.5%) |
| Dec 2004 | -$6.14M(+29.1%) | -$1.79M(-20.1%) | -$6.14M(+4.6%) |
| Sep 2004 | - | -$2.24M(+127.2%) | -$5.87M(+3.6%) |
| Jun 2004 | - | -$986.70K(-12.1%) | -$5.67M(+3.8%) |
| Mar 2004 | - | -$1.12M(-26.2%) | -$5.46M(+14.7%) |
| Dec 2003 | -$4.76M(+367.3%) | -$1.52M(-25.4%) | -$4.76M(+55.0%) |
| Sep 2003 | - | -$2.04M(+162.4%) | -$3.07M(+89.6%) |
| Jun 2003 | - | -$777.00K(+84.0%) | -$1.62M(+48.4%) |
| Mar 2003 | - | -$422.20K(-350.9%) | -$1.09M(-16.0%) |
| Dec 2002 | -$1.02M(-67.2%) | $168.30K(-128.6%) | -$1.30M(-35.9%) |
| Sep 2002 | - | -$588.20K(+136.4%) | -$2.02M(-5.4%) |
| Jun 2002 | - | -$248.80K(-60.5%) | -$2.14M(-36.4%) |
| Mar 2002 | - | -$629.60K(+12.8%) | -$3.37M(+13.7%) |
| Dec 2001 | -$3.11M(-1.7%) | -$558.20K(-20.8%) | -$2.96M(+3382.8%) |
| Sep 2001 | - | -$704.50K(-52.2%) | -$85.00K(-75.3%) |
| Jun 2001 | - | -$1.47M(+556.6%) | -$344.00K(-82.5%) |
| Mar 2001 | - | -$224.40K(-109.7%) | -$1.97M(-37.4%) |
| Dec 2000 | -$3.16M(+17.1%) | $2.32M(-340.5%) | -$3.15M(-48.1%) |
| Sep 2000 | - | -$963.50K(-68.9%) | -$6.06M(+8.3%) |
| Jun 2000 | - | -$3.10M(+120.8%) | -$5.60M(+74.9%) |
| Mar 2000 | - | -$1.40M(+133.8%) | -$3.20M(+14.4%) |
| Dec 1999 | -$2.70M(-15.6%) | -$600.00K(+20.0%) | -$2.80M(-22.2%) |
| Sep 1999 | - | -$500.00K(-28.6%) | -$3.60M(-16.3%) |
| Jun 1999 | - | -$700.00K(-30.0%) | -$4.30M(+53.6%) |
| Mar 1999 | - | -$1.00M(-28.6%) | -$2.80M(-9.7%) |
| Dec 1998 | -$3.20M(-39.6%) | -$1.40M(+16.7%) | -$3.10M(-6.1%) |
| Sep 1998 | - | -$1.20M(-250.0%) | -$3.30M(+6.5%) |
| Jun 1998 | - | $800.00K(-161.5%) | -$3.10M(-44.6%) |
| Mar 1998 | - | -$1.30M(-18.8%) | -$5.60M(+9.8%) |
| Dec 1997 | -$5.30M(+43.2%) | -$1.60M(+60.0%) | -$5.10M(+10.9%) |
| Sep 1997 | - | -$1.00M(-41.2%) | -$4.60M(-2.1%) |
| Jun 1997 | - | -$1.70M(+112.5%) | -$4.70M(+30.6%) |
| Mar 1997 | - | -$800.00K(-27.3%) | -$3.60M(+33.3%) |
| Dec 1996 | -$3.70M | -$1.10M(0.0%) | -$2.70M(+68.8%) |
| Sep 1996 | - | -$1.10M(+83.3%) | -$1.60M(+220.0%) |
| Jun 1996 | - | -$600.00K(-700.0%) | -$500.00K(-600.0%) |
| Mar 1996 | - | $100.00K | $100.00K |
FAQ
- What is TG Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for TG Therapeutics?
- What is TG Therapeutics annual EBIT year-on-year change?
- What is TG Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for TG Therapeutics?
- What is TG Therapeutics quarterly EBIT year-on-year change?
- What is TG Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for TG Therapeutics?
- What is TG Therapeutics TTM EBIT year-on-year change?
What is TG Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TGTX is $49.62M
What is the all time high annual EBIT for TG Therapeutics?
TG Therapeutics all-time high annual earnings before interest & taxes is $49.62M
What is TG Therapeutics annual EBIT year-on-year change?
Over the past year, TGTX annual earnings before interest & taxes has changed by +$23.95M (+93.25%)
What is TG Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TGTX is $12.22M
What is the all time high quarterly EBIT for TG Therapeutics?
TG Therapeutics all-time high quarterly earnings before interest & taxes is $117.64M
What is TG Therapeutics quarterly EBIT year-on-year change?
Over the past year, TGTX quarterly earnings before interest & taxes has changed by +$20.61M (+245.71%)
What is TG Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TGTX is $70.37M
What is the all time high TTM EBIT for TG Therapeutics?
TG Therapeutics all-time high TTM earnings before interest & taxes is $108.19M
What is TG Therapeutics TTM EBIT year-on-year change?
Over the past year, TGTX TTM earnings before interest & taxes has changed by +$16.69M (+31.10%)